Collplant Biotechnologies Ltd
NASDAQ:CLGN

Watchlist Manager
Collplant Biotechnologies Ltd Logo
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Watchlist
Price: 3.44 USD 0.88% Market Closed
Market Cap: 39.4m USD
Have any thoughts about
Collplant Biotechnologies Ltd?
Write Note

Collplant Biotechnologies Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Collplant Biotechnologies Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Income from Continuing Operations
-$7m
CAGR 3-Years
-7%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Income from Continuing Operations
$15.7m
CAGR 3-Years
65%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Enlivex Therapeutics Ltd
NASDAQ:ENLV
Income from Continuing Operations
-$22.3m
CAGR 3-Years
-16%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
Income from Continuing Operations
-$115.4m
CAGR 3-Years
-1%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Income from Continuing Operations
-$7.2m
CAGR 3-Years
28%
CAGR 5-Years
6%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Income from Continuing Operations
-â‚Ş29.2m
CAGR 3-Years
26%
CAGR 5-Years
-5%
CAGR 10-Years
-9%
No Stocks Found

Collplant Biotechnologies Ltd
Glance View

Market Cap
39.4m USD
Industry
Biotechnology

CollPlant Biotechnologies Ltd. is a regenerative medicine company, which engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

CLGN Intrinsic Value
15.33 USD
Undervaluation 78%
Intrinsic Value
Price

See Also

What is Collplant Biotechnologies Ltd's Income from Continuing Operations?
Income from Continuing Operations
-7m USD

Based on the financial report for Dec 31, 2023, Collplant Biotechnologies Ltd's Income from Continuing Operations amounts to -7m USD.

What is Collplant Biotechnologies Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-2%

Over the last year, the Income from Continuing Operations growth was 59%. The average annual Income from Continuing Operations growth rates for Collplant Biotechnologies Ltd have been -7% over the past three years , -2% over the past five years .

Back to Top